DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Cortes J, Estey E, O'Brien S, Giles F, Shen Y, Koller C, Beran M, Thomas D, Keating M, Kantarjian H.
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.
Cancer 2001; 92: 7-14
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.